Global Healthcare Opportunities Capital Partners, a European specialist investor in global healthcare, has acquired Genesis Research from Rallyday Partners, a private equity firm.
Genesis is a market participant in the growing field of real-world evidence and services market, leading innovators across the life sciences industry. The firm optimizes drug development and evidences the clinical and commercial value of products through the implementation of real-world data. The firm’s research enables pharma customers to work efficiently and improve its demonstration of drug efficacy.
“We are honored that we supported Genesis as its first outside investor and the tremendous progress we made together as partners,” commented the partners at Rallyday. “We are elated that GHO will lead Genesis Research to new levels of positive impact in the life sciences sector and we are humbled that this transaction is supporting the work of our investors who invest on behalf of university endowments and other philanthropic activities.”
Berg Hill Greenleaf Ruscitti, LLP acted as legal advisor to Genesis and Piper Sandler as financial advisor.